CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-02 | Khosla Rachna SVP, Business Development | Grant or award | +593 | 7,677 | ||
| 2023-05-02 | Khosla Rachna SVP, Business Development | Grant or award · Nqso (Right to Buy) | +5,016 | 5,016 | ||
| 2023-05-02 | Gordon Murdo EVP, Global Commercial Ops | Grant or award | +4,237 | 55,348 | ||
| 2023-05-02 | Gordon Murdo EVP, Global Commercial Ops | Grant or award · Nqso (Right to Buy) | +35,833 | 35,833 | ||
| 2023-05-02 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award | +3,390 | 40,767 | ||
| 2023-05-02 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award · Nqso (Right to Buy) | +28,666 | 28,666 | ||
| 2023-05-02 | Griffith Peter H. EVP & CFO | Grant or award | +3,814 | 32,598 | ||
| 2023-05-02 | Griffith Peter H. EVP & CFO | Grant or award · Nqso (Right to Buy) | +32,250 | 32,250 | ||
| 2023-05-02 | Bradway Robert A Chairman, CEO and President | Grant or award | +13,486 | 646,680 | ||
| 2023-05-02 | Bradway Robert A Chairman, CEO and President | Grant or award · Nqso (Right to Buy) | +114,040 | 114,040 |
Page 22 of 22 · 430 trades